These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Endoscopic treatment of moderate and high grade vesicoureteral reflux in infants using dextranomer/hyaluronic acid. Puri P, Mohanan N, Menezes M, Colhoun E. J Urol; 2007 Oct; 178(4 Pt 2):1714-6; discussion 1717. PubMed ID: 17707016 [Abstract] [Full Text] [Related]
6. Pseudodistal ureteral stone resulting from calcified Deflux implantation. Polcari AJ, Kim DY, Helfand BT, Lewis JM, Chaviano AH. Urology; 2009 Oct; 74(4):906-7. PubMed ID: 19616832 [Abstract] [Full Text] [Related]
7. Recent trends in the surgical management of primary vesicoureteral reflux in the era of dextranomer/hyaluronic acid. Herbst KW, Corbett ST, Lendvay TS, Caldamone AA. J Urol; 2014 May; 191(5 Suppl):1628-33. PubMed ID: 24679885 [Abstract] [Full Text] [Related]
8. Multivariate comparison of the efficacy of intraureteral versus subtrigonal techniques of dextranomer/hyaluronic acid injection. Routh JC, Reinberg Y, Ashley RA, Inman BA, Wolpert JJ, Vandersteen DR, Husmann DA, Kramer SA. J Urol; 2007 Oct; 178(4 Pt 2):1702-5; discussion 1705-6. PubMed ID: 17707019 [Abstract] [Full Text] [Related]
10. Appearance of dextranomer/hyaluronic Acid copolymer implants on computerized tomography after endoscopic treatment of vesicoureteral reflux in children. Cerwinka WH, Qian J, Easley KA, Scherz HC, Kirsch AJ. J Urol; 2009 Mar; 181(3):1324-8; discussion 1329. PubMed ID: 19157427 [Abstract] [Full Text] [Related]
11. Treatment of vesicoureteral reflux using endoscopic injection of nonanimal stabilized hyaluronic acid/dextranomer gel: initial experience in pediatric patients by a single surgeon. Yu RN, Roth DR. Pediatrics; 2006 Aug; 118(2):698-703. PubMed ID: 16882825 [Abstract] [Full Text] [Related]
12. The cost-effectiveness of dextranomer/hyaluronic acid copolymer for the management of vesicoureteral reflux. 2. Reflux correction at the time of diagnosis as a substitute for traditional management. Benoit RM, Peele PB, Cannon GM, Docimo SG. J Urol; 2006 Dec; 176(6 Pt 1):2649-53; discussion 2653. PubMed ID: 17085183 [Abstract] [Full Text] [Related]
13. Cystoscopic injections of dextranomer hyaluronic acid into proximal urethra for urethral incompetence: efficacy and adverse outcomes. Lightner DJ, Fox J, Klingele C. Urology; 2010 Jun; 75(6):1310-4. PubMed ID: 20299087 [Abstract] [Full Text] [Related]
14. Acute and delayed vesicoureteral obstruction after endoscopic treatment of primary vesicoureteral reflux with dextranomer/hyaluronic acid copolymer: why and how to manage. García-Aparicio L, Rodo J, Palazon P, Martín O, Blázquez-Gómez E, Manzanares A, García-Smith N, Bejarano M, de Haro I, Ribó JM. J Pediatr Urol; 2013 Aug; 9(4):493-7. PubMed ID: 23507288 [Abstract] [Full Text] [Related]
15. Febrile urinary tract infections after ureteroneocystostomy and subureteral injection of dextranomer/hyaluronic acid for vesicoureteral reflux--do choice of procedure and success matter? Dwyer ME, Husmann DA, Rathbun SR, Weight CJ, Kramer SA. J Urol; 2013 Jan; 189(1):275-82. PubMed ID: 23174239 [Abstract] [Full Text] [Related]